Injector and syringe, angiographic: medical device reports filed with FDA

3,323 reports carry this product code, 1992–2026; 8 brands with a page.

Read first · FDA's statement on these data

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product. openFDA, FDA

FDA adds: "Although MDRs are a valuable source of information, this passive surveillance system has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data. In addition, the incidence or prevalence of an event cannot be determined from this reporting system alone due to potential under-reporting of events and lack of information about frequency of device use." And: "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices."

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

3,323
reports with this product code: 0% of all MAUDE reports; 142
reports, 12 months to August 2026: 111 in the 12 months before; 54%
classified as malfunction: 62.3% across all reports; 4.4%
classified as death, as reported: 0.9% across all reports

Product code DXT is FDA's classification for "Injector and syringe, angiographic" (cardiovascular panel), a class 2 device. 3,323 medical device reports carry this product code, 0% of the MAUDE database, from March 1992 to August 2026.

142 reports arrived in the 12 months to August 2026, up 28% from 111 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (54%), injury (32%) and other (8.4%). 8 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Brands with this product code

Brand	Reports	Latest 12 months	Classified as death	Classified as malfunction
Acist	312	14	10.6%	14.9%
Stellant Dual Ct Injector	236	12	8.1%	26.3%
Medrad Ct Injector	150	0	2.9%	18.4%
Boston Scientific	61	5	3.3%	55%
BD Syringe	20	117	0.4%	94.6%
Deroyal	6	14	0.7%	72.7%
Navilyst Medical	6	0	0.4%	90.9%
Bd	2	0	1%	56%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Manufacturers named

Manufacturer (as written on reports)	Reports	Share
Liebel-Flarsheim	538	16.2%
B Braun Medical	85	2.6%
Merit Medical Systems	62	1.9%
Covidien	57	1.7%
Becton Dickinson	11	0.3%
Deroyal Industries	6	0.2%
Bayer	4	0.1%
Angiodynamics	3	0.1%
Lemaitre Vascular	3	0.1%
Medex	3	0.1%
Arrow International	2	0.1%
Bayer Healthcare	2	0.1%
Becton Dickinson Medical Systems	1	0%
Cordis Neurovascular	1	0%

Reports by month, five years

FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

Event type and report source

Event type

Death4.4%146

Injury32%1,062

Malfunction54%1,793

Other8.4%280

Not given1.3%42

Who filed

Manufacturer report81.7%2,715

Voluntary report7.1%236

User facility report0%0

Distributor report0.2%6

Not given11%366

Grey bar: all 26,136,888 MAUDE reports.

Device problems coded

Device problem (FDA code)	Reports	Share
Air leak	312	9.4%
Insufficient device problem information	199	6%
Breakthe device broke	182	5.5%
Detachment of device component	147	4.4%
Device contamination with chemical or other material	146	4.4%
Device operates differently than expectedthe device behaved unexpectedly	117	3.5%
Component falling	107	3.2%
Fluid/blood leak	95	2.9%
Improper or incorrect procedure or method	93	2.8%
Bubble(s)	83	2.5%
Self-activation or keying	65	2%
Component(s), broken	64	1.9%
Crackthe device cracked	59	1.8%
Manufacturing, packaging or shipping problem	53	1.6%
Device displays incorrect message	47	1.4%
Replace	46	1.4%
Loose or intermittent connection	42	1.3%
Detachment of device or device componentpart of the device came off	41	1.2%
Material separation	39	1.2%
Leak/splashthe device leaked	38	1.1%

Questions about injector and syringe, angiographic reports

What is product code DXT?

FDA's classification code for "Injector and syringe, angiographic", class 2, reviewed by the cardiovascular panel. Every device report carries the product code of the device involved.

How many reports carry this code?

3,323 reports through August 2026, 142 of them in the latest 12 months.

Which brands appear most often?

Acist (312), Stellant Dual Ct Injector (236), Medrad Ct Injector (150), Boston Scientific (61) and BD Syringe (20). Widely used products collect more reports because more people use them.

Can the brands table be used to rank the devices?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.